This site is intended for Healthcare Professionals only
2024-06-18 13:00:05 (1 year(s) ago)
Teva UK Limited has informed the MHRA that it plans to withdraw from further sale all batches of GoResp Digihaler (budesonide and formoterol fumarate dihydrate) and the linked Digihaler App for commercial reasons.